Related Experiment Video
Updated: Sep 27, 2025

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
PAK-dependent regulation of actin dynamics in breast cancer cells
Marianne Best1, Madeline E Gale2, Claire M Wells1
1School of Cancer and Pharmaceutical Sciences, Kings College London, London UK.
Abstract:
Metastatic Breast Cancer has a poor 25% survival rate and currently there are no clinical therapeutics which target metastasis. 'Migrastatics' are a new drug class which target migration pathway effector proteins in order to inhibit cancer cell invasion and metastasis. The p21-activated kinases (PAKs) are essential drivers of breast cancer cell migration and invasion through their regulation of actin cytoskeletal dynamics. Therefore, the PAKs present as attractive migrastatic candidates. Here we review how PAKs regulate distinct aspects of breast cancer actin dynamics focussing on cytoskeletal reorganisation, cell:matrix adhesion, actomyosin contractility and degradative invasion. Lastly, we discuss the introduction of PAK migrastatics into the well-honed breast cancer clinical pipeline.
Insights
Migrastatics, a new drug class, target p21-activated kinases (PAKs) to inhibit breast cancer metastasis. This review explores how PAKs drive actin dynamics crucial for cancer cell invasion and discusses PAK migrastatics in clinical settings.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Metastatic breast cancer has a poor 25% survival rate.
- Current treatments do not target cancer metastasis.
- Migrastatics are an emerging drug class designed to inhibit cancer cell invasion and metastasis by targeting migration pathway effector proteins.
Purpose of the Study:
- To review the role of p21-activated kinases (PAKs) in regulating actin dynamics in breast cancer cell migration and invasion.
- To highlight PAKs as potential targets for novel migrastatic therapeutics.
- To discuss the clinical potential of PAK migrastatics in breast cancer treatment.
Main Methods:
- Review of existing literature on PAKs and breast cancer metastasis.
- Analysis of PAK regulation of actin cytoskeletal dynamics, including cytoskeletal reorganisation, cell:matrix adhesion, actomyosin contractility, and degradative invasion.
- Discussion of the clinical pipeline for migrastatic drug development.
Main Results:
- PAKs are essential drivers of breast cancer cell migration and invasion.
- PAKs regulate key aspects of actin dynamics that facilitate metastasis.
- PAKs represent attractive targets for the development of migrastatic drugs.
Conclusions:
- Targeting PAKs offers a promising strategy for developing novel migrastatic therapies for metastatic breast cancer.
- Understanding PAK-mediated actin dynamics is crucial for designing effective anti-metastatic drugs.
- The integration of PAK migrastatics into the breast cancer clinical pipeline holds significant therapeutic potential.
More Related Videos
Related Concept Videos
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
Destabilization of Microtubules
Mechanism of Lamellipodia Formation
Introduction to Actin

